SIBA
:Type 1 and 2 diabetes
:Phase 3
SIBA is a neutral, soluble, long-acting new generation of insulin with a flat and predictable profile, potentially providing more than 24-hour coverage by once-daily injection.
- Company announcements
- No company announcements matching the search criteria
- Press releases
- No press releases matching the search criteria
- Scientific abstracts
No scientific abstracts matching the search criteria
